Oncology
5,176 studies502 in 7 days2,477 in 30 days
Filters
Latest
5,176 studies
- Cancer patient outcomes correlate with activating-KIR/ligand repertoires associated with distinct NK cell transcriptomic profiles
- 523 Lymphaticsparing neoadjuvant SABR and pembrolizumab (neo-ImmunoSABR) in HPVnegative HNSCC: results from a phase II multi-center trial with immune correlates
- 524 Zopapogene imadenovec-drba, a novel adenovector-based immunotherapy, induces complete and durable responses in recurrent respiratory papillomatosis
- 683 Single-cell RNA-seq analysis of 9464D-GD2 neuroblastoma reveals immune remodeling after anti-CD40 and epigenetic modifier inhibitor therapy
- 455 Second primary malignancy risk in the immunotherapy era among urothelial carcinoma survivors: a SEER population-based analysis
- Competências do Nurse Navigator no Cuidado à Pessoa Submetida a Laringectomia Total: uma Scoping Review
- Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance
- From chronic airway injury to lung cancer: epithelial memory, field cancerization, and premalignant evolution
- CK20/CK7 double-negative merkel cell carcinoma arising within a previously photodynamic-therapy-treated actinic keratosis field: a case report
- VRK2 promotes HCC metastasis by enhancing autophagy-mediated degradation of ZO-1
- Clinical outcomes of targeted treatment strategies for primary non-small cell lung cancer with MET alterations: a systematic review and meta-analysis
- Temporal muscle thickness and the survival of patients with IDH-wildtype glioblastoma: a meta-analysis
- Association between preoperative MRI-measured membranous urethral length and early urinary continence recovery after robot-assisted radical prostatectomy: a retrospective cohort study
- Stem cell mobilization with G-CSF and on-demand plerixafor in newly diagnosed multiple myeloma patients treated with daratumumab: a single-center experience
- Transcript Abundance of IL6, CXCL9, LIF and LIFR in Glottic Lesions: Relationship to Histology and to Narrow-Band Imaging Vascular Patterns
- Negative-Control Calibration and E-Value Bounding of Cancer-Survivor Mortality Contrasts: A Design-Aware Competing-Risks Analysis
- Late Vertebral Metastasis in Long-Term Survivors of Breast, Prostate, and Renal Cell Cancer
- Early Patient-Reported Outcomes and Graft-Versus-Host Disease as Indicators of Long-Term Quality of Life and Fatigue After Allogeneic Hematopoietic Stem Cell Transplantation: A 24-Month Prospective Study
- Real-World Outcomes of Oral VEGFR Tyrosine Kinase Inhibitor-Containing Therapy in Unresectable Malignant Mesothelioma: A Single-Center Retrospective Study
- Real-World Direct Medical Costs and Clinical Outcomes of Immunotherapy and Targeted Therapy for Cutaneous Melanoma: A Bottom-Up Cost-of-Illness Study in a Public Healthcare System
- Evolving Trends in Early-Onset and Young Adult Gastrointestinal Cancer: Philadelphia in a National Context
- Targeting tankyrase scaffolding in the β-catenin destruction complex by PROTAC overcomes the limitation of catalytic inhibitors in colorectal cancer
- Epigenetic and RNA control of cancer stem cell plasticity and therapy resistance
- Radiomics-driven multimodal integration in precision radiotherapy for nasopharyngeal carcinoma— current evidence, clinical barriers, and future directions
- Long-Term Impact of First-Line Amivantamab Plus Lazertinib Versus Osimertinib on Mechanisms of Acquired Resistance in MARIPOSA: A Brief Report